指南与共识胸部肿瘤

IV期驱动基因阳性非小细胞肺癌的治疗:ASCO动态指南2024.1版

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1.
指南 / 共识 · J Clin Oncol · 2024-05-30

ASCO针对IV期驱动基因阳性非小细胞肺癌发布2024.1版动态指南,由常设专家 panel 持续系统审查文献并定期更新推荐,内容不替代临床医生的独立专业判断。

要点

  • 本指南为ASCO动态指南2024.1版,针对IV期驱动基因阳性非小细胞肺癌的治疗。
  • 由常设专家 panel 持续系统审查健康文献并定期更新推荐。
  • 指南不替代治疗医生的独立专业判断,亦未考虑患者个体差异。

核心结论

  • ASCO动态指南针对IV期驱动基因阳性非小细胞肺癌的治疗推荐会定期更新,最新版本为2024.1版。

研究设计与样本

  • 由常设专家 panel 按照ASCO指南方法学手册,持续系统审查健康文献并定期更新推荐。

临床怎么用

  • 原文指出动态指南及更新不替代治疗医生的独立专业判断,且未考虑患者个体差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2). Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Owen DH, Ismaila N, Freeman-Daily J, et al. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1. J Clin Oncol. 2024. PMID: 38815183. doi:10.1200/JCO.24.00762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。